GlassScriptPhysician profile
Erron Kinsler
NPI 1194827469
$13,039.71
in general payments reported to CMS, 2019-2025
18 companies · $751 in 2025
The $751 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.28 · 2023: $10K · 2024: $1,969 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $2,056 · Travel and Lodging: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,006.90 |
| Food and Beverage | $2,055.75 |
| Travel and Lodging | $922.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,311.78 | 2023-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Hologic Sales and Service, LLC | $322.30 | 2022-2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Medtronic, INC. | $294.13 | 2023-2025 | Truclear, Linq II |
| Astellas Pharma US INC | $261.36 | 2024-2025 | Veozah |
| Organon LLC | $251.93 | 2022-2025 | Nexplanon |
| Baxter Healthcare | $116.57 | 2024-2025 | Perclot |
| Ethicon US, LLC | $85.95 | 2023 | Dermabond, Stratafix, Enseal |
| Sumitomo Pharma America, INC. | $73.39 | 2023-2025 | Myfembree |
| Biogen, INC. | $69.14 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $55.13 | 2025 | |
| Aspira Women'S Health INC | $44.78 | 2024 | Ova1 |
| Coopersurgical, INC. | $38.59 | 2025 | Paragard T 380a, Sos |
| Optumhealth Care Solutions, LLC | $34.48 | 2023-2025 | Vivify Health Care Team Portal, Eitan Medical, Vivify Health Care Team Portal 001 |
| Avanos Medical | $18.91 | 2023 | On-Q* Pump and Accessories |
| Myovant Sciences INC. | $17.50 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.34 | 2025 | Slynd |
| Kowa Pharmaceuticals America, INC. | $14.29 | 2023 | Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $14.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erron Kinsler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.